Literature DB >> 8846171

The influence of smoking cessation and hypertriglyceridaemia on the progression of peripheral arterial disease and the onset of critical ischaemia.

I Smith1, P J Franks, R M Greenhalgh, N R Poulter, J T Powell.   

Abstract

OBJECTIVE: To investigate whether smoking and other cardiovascular risk factors were associated with deterioration of ankle/brachial pressure index or onset of critical ischaemia in patients with mild to moderate intermittent claudication. DESIGN AND
SETTING: Longitudinal study in a London teaching hospital.
SUBJECTS: 415 consecutive smokers, with symptoms of intermittent claudication and an ankle/brachial pressure index of <0.9, referred for a surgical opinion between April 1985 and December 1990, who were not considered for an immediate surgical procedure. MAIN OUTCOME
RESULTS: Reduction in ankle/brachial pressure index of >0.14, onset of critical limb ischaemia.
RESULTS: After one year of follow up 183 patients (44%) had stopped smoking (as evaluated by biochemical markers). With longer follow up only 110 patients (27%) had maintained smoking cessation. There were no differences in age, sex, and previous tobacco exposure between stoppers and smokers, but the proportion of diabetics among stoppers (20%) was greater than among those who continued smoking (10%) [p=0.01]. The annual rate of deterioration of ABPI was 21, 16 and 17% respectively in the first, second and third year of follow-up and the onset of critical ischaemia was observed in 52 patients (12.5%) during the period of follow-up. In univariate analyses, continued smoking, diabetes and presence of ischaemic heart disease were not associated with an increased risk of deterioration of ABPI, but hypertriglyceridaemia (> or = 2.2 mmol/l) was, [relative risk 1.7(95% CI 1.21-2.37), p=0.003], and patients having systolic blood pressure in the middle tertile (153-170 mmHg had a reduced risk of deterioration of ABPI, p=0.026. Hypertriglyceridaemia (> or = 2.2mmol/l) was the only independent factor associated with deterioration of ABPI in multivariate analysis [relative risk 1.8(95% CI:1.23-2.59), p=0.003] and also was associated with a relative risk of onset of critical ischaemia of 1.9 [(95% CI: 1.08-2.87), p=0.035], compared with triglyceride levels of <2.2mmol/l.
CONCLUSION: For those with mild to moderate claudication, the lack of immediate benefit from cessation of smoking appears to be associated with a gradual return to smoking. Hypertriglyceridaemia was identified as the most important independent factor associated with the progression of peripheral arterial disease and onset of critical ischaemia.

Entities:  

Mesh:

Year:  1996        PMID: 8846171     DOI: 10.1016/s1078-5884(96)80170-5

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  6 in total

1.  The practical management of claudication.

Authors:  A Davies
Journal:  BMJ       Date:  2000-10-14

2.  Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease.

Authors:  Andrew M Wilson; David S Shin; Carlton Weatherby; Randall K Harada; Martin K Ng; Nandini Nair; Jan Kielstein; John P Cooke
Journal:  Vasc Med       Date:  2010-05-19       Impact factor: 3.239

3.  Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.

Authors:  Aaron W Aday; Patrick R Lawler; Nancy R Cook; Paul M Ridker; Samia Mora; Aruna D Pradhan
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

4.  Intermittent claudication: pharmacoeconomic and quality-of-life aspects of treatment.

Authors:  Gregorio Brevetti; Roberta Annecchini; Roxanna Bucur
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

5.  Active smoking is associated with higher rates of incomplete wound healing after endovascular treatment of critical limb ischemia.

Authors:  Damianos G Kokkinidis; Stefanos Giannopoulos; Moosa Haider; Timothy Jordan; Anita Sarkar; Gagan D Singh; Eric A Secemsky; Jay Giri; Joshua A Beckman; Ehrin J Armstrong
Journal:  Vasc Med       Date:  2020-05-27       Impact factor: 3.239

6.  Evaluation of serum adipokines in peripheral arterial occlusive disease.

Authors:  Claudia D Gherman; Aurel I Mironiuc
Journal:  Mediators Inflamm       Date:  2012-04-04       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.